The effectiveness of pneumococcal polysaccharide vaccine 23 (PPV23) in the general population of 50 years of age and older: A systematic review and meta-analysis

Clicks: 256
ID: 267982
2016
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
The vaccine effectiveness of PPV23 in preventing IPD and all-cause CAP was consistent with past systematic reviews and similar to the estimates that were reported in the CAPiTA trial evaluating the vaccine effectiveness of PCV13. Consistent benefits were also reported across ecological studies and r …
Reference Key
h2016vaccinethe Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Kraicer-Melamed H;O'Donnell S;Quach C;;
Journal Vaccine
Year 2016
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/26899372
Keywords
systematic review meta-analysis National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine aged middle aged community-acquired infections / microbiology pneumonia pneumococcal infections / prevention & control* pneumococcal vaccines / therapeutic use* community-acquired infections / prevention & control bacterial / prevention & control* data accuracy pmid:26899372 doi:10.1016/j.vaccine.2016.02.024 hannah kraicer-melamed shauna o'donnell caroline quach

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.